Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway.
Teinturier R, Luo Y, Decaussin-Petrucci M, Vlaeminck-Guillem V, Vacherot F, Firlej V, Bonnavion R, Abou Ziki R, Gherardi S, Goddard I, Gadot N, Bertolino P, Le Romancer M, Zhang CX.
Teinturier R, et al.
Oncogene. 2021 Feb;40(6):1118-1127. doi: 10.1038/s41388-020-01589-1. Epub 2020 Dec 15.
Oncogene. 2021.
PMID: 33323967